[Congressional Record Volume 148, Number 113 (Tuesday, September 10, 2002)]
[Senate]
[Page S8452]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
IMPROVING THE GENETIC NEWBORN SCREENING PROGRAM
Mr. DEWINE. Mr. President, on August 1, along with my colleague from
Connecticut, Senator Dodd, introduced a bill designed to improve the
Nation's current genetic newborn screening program. Our legislation
would provide education grants for physicians and parents, as well as
grants to States to improve follow-up and tracking of those children
who receive a heelstick screening and receive a positive result for
metabolic, genetic, infectious, and other congenital conditions that
threaten their health and life.
Each year, newborn screening identifies an estimated 3,000 babies
with conditions that would otherwise have had dire consequences. But
despite their clear importance, our newborn screening systems are
fragmented. Quite simply, all children do not have access to the same
genetic tests. Where a child is born and what tests are offered in that
State is what determines the tests a newborn receives. In my home State
of Ohio, we test for 12 disorders, while right across the border in
Kentucky, they test for only four disorders and in Pennsylvania, they
test for five. In Massachusetts, however, newborns are tested for 29
disorders.
Furthermore, parents often are not sufficiently informed of the
number of tests available in their state and what those tests can help
accomplish. Physicians may not know to educate parents, or physicians
may talk to parents too late in the birthing process for it to make a
difference. Also, State health departments may not follow-up adequately
with the parents of a child who receives a positive test result, and
health departments may not have the capacity to effectively record or
track a large number of positive results.
The bill we are introducing today would go a long way toward
streamlining the current newborn screening system by offering states
grants to accomplish the following: build and expand existing
procedures and systems to report test results to individuals and
families, and primary care physicians and subspecialties; coordinate
ongoing follow-up treatment with individuals, families, and primary
care physicians after a newborn receives an indication of the presence
of a disorder on a screening test; ensure seamless integration of
confirmatory testing, tertiary care, genetic services, including
counseling, and access to developing therapies by participation in
approved clinical trials involving the primary health care of the
infant; and analyze collected data to identify populations at high
risk, examine and respond to health concerns, recognize and address
relevant environmental, behavioral, socioeconomic, demographic, and
other factors.
This bill is a good start toward ensuring that all newborns receive
equal access to genetic tests and that their follow-up care, if needed,
is available and coordinated. The importance of these screenings cannot
be overstated. It can mean the difference between life and death for a
newborn. And that, is something we must address.
I ask my colleagues for their support.
____________________